Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 3, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • ROS generation by Schistosome eggs boost hepatic pathology

Sea corals – A new way to combat heat stress

Visuospatial oscillations in Alzheimer’s disease associated cognitive decline

ROS generation by Schistosome eggs boost hepatic pathology
  • BiotechToday
  • World

ROS generation by Schistosome eggs boost hepatic pathology

BioTech Today August 19, 2021August 19, 2021

Saptaparna Dasgupta, Bennett University

Schistosomiasis is a disregarded public health tropical disease. The most serious disease is largely attributable to the grain produced by eggs and subsequent fibrosis in the host liver. This may lead to portal hypertension or even the death of the host. Host disease is most commonly observed, schistosome eggs produce M2-rich granulomas, which are very important in maintaining granulomas and eventual fibrosis. These M2-macrophages play an integral role. Reactive oxygen (ROS) species strongly activated during infection generated by macrophages are disseminated massively surrounding eggs deposited in the liver, facilitating differentiation of M2 macrophage. It remains, however, to be clarified during Schistosoma japonicum infection if ROS is produced by schistosome eggs to further differentiate M2 by macrophage and the underlying potential processes.

Schistosomiasis:

The schistosomiasis of ~200 million individuals, particularly in (sub)tropic regions, is a neglected parasite poverty disease, leading to a huge health burden and considerable morbidity. Parasite eggs are trapped in the host’s liver and cause hepatic granulomas and fibrosis during Schistosoma japonicum or the infection of S. mansoni, leading to serious damage to the liver and even death of the host. Significant ROS accumulates in granulomas around hepatic schistosomiasis in eggs caught by the hepatic. However, the fact whether schistosome eggs induce ROS generation and how ROS supports hepatic disease in the host remains unclear.

Role of macrophage in schistosomiasis:

The introduction, maintenance, and resolution of chronic granulomatous inflammation depending on their effector phenotypes are known to be regulated by macrophages in schistosome infections. It’s one of the most significant cell types in hepatic granuloma, and it’s involved in both innate and adaptive immunity. When responding to a variety of stimulations the macrophages are activated and polarized in functional terms to either M1 or M2. M1 macrophages are found to be schistosomula cytotoxic and also contribute to hepatic fibrosis prevention. Macrophages create significant levels of ROS, as professional phagocytes, as their main instrument against invading pathogens. They are one of the major cell sources of ROS generation during hepatic fibrosis.

How was the study conducted?

The study by Yu et al. 2021 was performed on mouse animal models, and all studies were carried out in complete compliance with the Experimental Animal Administration Regulations. The Animal Center of Nanjing Medical University bought Specific pathogen-free (SPF) male 8-week-old male BALB/c mice (Nanjing, China). All the mice were raised in an SPF breeding facility under normal circumstances. For semi-quantitative examination of hepatic fibrosis, the liver slices were stained with the Masson’s Trichrome staining kit (Sigma-Aldrich). Followed by which, the ROS generation was measured in the mouse livers. Several analyses such as the serum ALT/AST, flow cytometry analysis, western blotting, and statistical analysis were performed.

Findings of the study:

Infection with Schistosoma japonicum produces granulomatous inflammation and fibrosis in the liver of the host. Mice infected with S. Japonicum had significant liver immunopathology, as well as gastrointestinal inflammation. In mice, the buildup of reactive oxygen species (ROS) contributes to hepatic immunopathology. Macrophages are well-known for their ability to generate a high quantity of reactive oxygen species (ROS) during hepatic inflammation and fibrosis caused by alcohol, lipid buildup, endotoxins, and viral infections. On hepatic schistosomiasis, no comparable information is known. During infection, schistosome eggs have been shown to enhance M2 macrophage development and generate M2-rich granulomas. It’s unclear if ROS generation stimulation is required for M2 macrophage differentiation caused by Schistosoma japonicum eggs.

Significance of the study:

Pathogens cause the host to produce a large amount of ROS. Significant levels of ROS develop in granulomas around liver-trapped eggs during hepatic schistosomiasis. The specific mechanisms by which ROS regulate granulomatous inflammation to induce fibrosis to become a focus of research. Increased ROS function as second messengers in macrophages and promote fibrosis, according to previous research. Our findings point to a previously unknown immunological function for ROS in increasing M2 macrophage differentiation and Th2 responses in hepatic schistosomiasis, which results in liver damage. In conclusion, our findings reveal that ROS buildup in the liver of Schistosoma japonicum infected mice leads to hepatic immunopathology and that schistosome eggs cause ROS production to enhance M2 macrophage development.

Also read: Inborn errors of immunity & corresponding protein interactions

Reference:

  1. Yu, Y., Wang, J., Wang, X., Gu, P., Lei, Z., Tang, R., Wei, C., Xu, L., Wang, C., Chen, Y., Pu, Y., Qi, X., Yu, B., Chen, X., Zhu, J., Li, Y., Zhang, Z., Zhou, S., & Su, C. (2021). Schistosome eggs stimulate reactive oxygen species production to enhance M2 macrophage differentiation and promote hepatic pathology in schistosomiasis. PLOS Neglected Tropical Diseases, 15(8), e0009696. https://doi.org/10.1371/journal.pntd.0009696
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Saptaparna Dasgupta, currently a B. Tech 3rd year student, pursuing Biotechnology, is a diligent student and determined in terms of her career goals. Being a budding biotechnologist, she is open to all research fields of her course and passionate about knowledge. She is focused and constantly tries to improve her writing skills, also a project enthusiast and is fond of gaining hands-on experience in laboratories. She believes that all hard works and effort pay off eventually and follows this as the motto of her life.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged hepatic fibrosis hepatology liver macrophages Mouse models pathogen phagocytes reactive oxygen species schistosome eggs schistosomiasis Th2 responses

One thought on “ROS generation by Schistosome eggs boost hepatic pathology”

  1. Pingback: Dungeons and Dragons as behavioural therapy - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Visuospatial oscillations in Alzheimer’s disease associated cognitive decline

BioTech Today August 19, 2021

Kanikah Mehndiratta, MSc, University of Glasgow Alzheimer’s disease (AD) is a progressive neurodegenerative condition that causes brain atrophy or shrinking, ultimately leading to death of brain cells. It is considered to be the biggest cause of dementia globally. The death rate due to AD in U.S came out as 37 per 100,000 people in 2019. […]

Visuospatial

Related Post

  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

ARE TEMPERATURE CHECKS A GOOD WAY FOR ASSESSING COVID-19?

bioxone September 16, 2020September 16, 2020

– Husna, Amity University Kolkata Recently, as the world is implementing re-opening plans during the COVID-19 pandemic, infrared contact-free temperature assessment devices are being used at entry points to identify and screen out feverish individuals who may carry the coronavirus. But even when the devices are used properly, temperature assessment may have a limited impact […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Blink rate to measure stress and attention in horses

bioxone December 15, 2020December 14, 2020

Sampriti Roy, University of Calcutta The 21st century has seen the rise of many novel methods of diagnosis and surgery. Non-invasive/ minimally invasive procedures are one of them. Without breaking the skin of an individual, non-invasive procedures reduce the risks and discomfort that an individual would face in invasive methods and when it comes to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy